Charles River Laboratories total liabilities and share holders equity for the quarter ending June 30, 2024 was $7.948B, a 2.26% increase year-over-year.
Charles River Laboratories total liabilities and share holders equity for 2023 was $8.195B, a 7.79% increase from 2022.
Charles River Laboratories total liabilities and share holders equity for 2022 was $7.603B, a 8.24% increase from 2021.
Charles River Laboratories total liabilities and share holders equity for 2021 was $7.024B, a 27.93% increase from 2020.
Charles River Laboratories Total Liabilities and Share Holders Equity 2010-2024 | CRL